The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
- PMID: 28018980
- PMCID: PMC5176078
- DOI: 10.12688/wellcomeopenres.9961.1
The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
Abstract
Background: Down syndrome (DS), the most common genetic cause of intellectual disability, is associated with an ultra-high risk of developing Alzheimer's disease. However, there is individual variability in the onset of clinical dementia and in baseline cognitive abilities prior to decline, particularly in memory, executive functioning, and motor coordination. The LonDownS Consortium aims to determine risk and protective factors for the development of dementia and factors relating to cognitive abilities in people with DS. Here we describe our cognitive test battery and related informant measures along with reporting data from our baseline cognitive and informant assessments.
Methods: We developed a cognitive test battery to assess general abilities, memory, executive function, and motor coordination abilities in adults with DS, with informant ratings of similar domains also collected, designed to allow for data on a broad range of participants. Participants (n=305) had a range of ages and abilities, and included adults with and without a clinical diagnosis of dementia.
Results: Results suggest the battery is suitable for the majority of adults with DS, although approximately half the adults with dementia were unable to undertake any cognitive task. Many test outcomes showed a range of scores with low floor and ceiling effects. Non-verbal age-adjusted IQ scores had lower floor effects than verbal IQ scores. Before the onset of any cognitive decline, females aged 16-35 showed better verbal abilities compared to males. We also identified clusters of cognitive test scores within our battery related to visuospatial memory, motor coordination, language abilities, and processing speed / sustained attention.
Conclusions: Our further studies will use baseline and longitudinal assessments to explore factors influencing cognitive abilities and cognitive decline related to ageing and onset of dementia in adults with DS.
Keywords: Alzheimer’s disease; Down syndrome; cognition; dementia; executive function; intellectual disability; memory; motor coordination.
Conflict of interest statement
AS has acted as an investigator for clinical trials sponsored by Roche Pharmaceuticals and consulted for Ono pharmaceuticals. He has been an adviser to the UK Down Syndrome Association and is an advisory board member of the LuMind Foundation (USA). No other authors have any competing interests to declare.
Similar articles
-
Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS).PLoS One. 2016 May 6;11(5):e0154596. doi: 10.1371/journal.pone.0154596. eCollection 2016. PLoS One. 2016. PMID: 27153191 Free PMC article.
-
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.Front Psychiatry. 2019 Apr 16;10:158. doi: 10.3389/fpsyt.2019.00158. eCollection 2019. Front Psychiatry. 2019. PMID: 31057430 Free PMC article.
-
[The estimation of premorbid intelligence levels in French speakers].Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. doi: 10.1016/s0013-7006(05)82370-x. Encephale. 2005. PMID: 15971638 French.
-
Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review.
-
Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan.J Neurodev Disord. 2018 Jan 29;10(1):5. doi: 10.1186/s11689-017-9220-y. J Neurodev Disord. 2018. PMID: 29378508 Free PMC article. Review.
Cited by
-
Characterizing the emergence of amyloid and tau burden in Down syndrome.Alzheimers Dement. 2024 Jan;20(1):388-398. doi: 10.1002/alz.13444. Epub 2023 Aug 29. Alzheimers Dement. 2024. PMID: 37641577 Free PMC article.
-
Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.Am J Alzheimers Dis Other Demen. 2018 Jun;33(4):253-262. doi: 10.1177/1533317518761093. Epub 2018 Mar 5. Am J Alzheimers Dis Other Demen. 2018. PMID: 29504408 Free PMC article. Review.
-
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.Alzheimers Res Ther. 2018 Apr 10;10(1):39. doi: 10.1186/s13195-018-0367-x. Alzheimers Res Ther. 2018. PMID: 29631614 Free PMC article.
-
Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome.Front Psychol. 2019 Jan 17;9:2730. doi: 10.3389/fpsyg.2018.02730. eCollection 2018. Front Psychol. 2019. PMID: 30705655 Free PMC article.
-
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.Alzheimers Dement (N Y). 2018 Dec 13;4:703-713. doi: 10.1016/j.trci.2018.10.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30581976 Free PMC article. Review.
References
-
- Aylward EH, Li Q, Honeycutt NA, et al. : MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am J Psychiatry. 1999;156(4):564–568. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources